Clinical Trials Browser

Interventional × ibrutinib × Tumor-Agnostic × Clear all

NCT03525925 2024-03-18

Ibrutinib and Nivolumab in Treating Participants With Metastatic Solid Tumors

Phase 1 Completed

Neoplasm Metastasis

NCT01704963 2018-02-05

A Study to Evaluate the Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 in Patients With Recurrent Mature B-Cell Neoplasms

Phase 1 Completed

Neoplasms